FDA (Drugs) recall action 79606
The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.
cGMP Deviations
The agency’s own wording, quoted from the enforcement report.
Elroselabs Inc. is voluntarily recalling Molleave, 2 oz bottles, due to current Good Manufacturing Practice (cGMP) deviations. The product was distributed nationwide.
Elroselabs Inc. is voluntarily recalling Conzerol Hydrogen Peroxide Gel 3% nationwide due to current Good Manufacturing Practice (cGMP) deviations.
Elroselabs Inc. is voluntarily recalling Conzerol topical cream nationwide due to cGMP deviations. The recall was initiated in March 2018 and terminated in December 2020.